Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with nasopharyngeal carcinoma (a type of cancer in the back of the nose/throat) confirmed by a biopsy, specifically classified as WHO Type II or III, and at Stage I (early stage)
- People who have not received any previous treatment for this cancer
- People between 18 and 70 years old
- People whose blood, liver, and kidney are functioning well enough to meet the trial's health requirements
- People who are generally well enough to carry out daily activities, with a low disability score on a standard medical scale (confirm with trial site)
- People who have given their signed agreement to participate in the trial
Who may not be able to join:
- People whose cancer has come back after treatment or has spread to other parts of the body
- People who have had any other type of cancer in the past, or who have received any prior treatment for this type of cancer
- People who have another serious, life-threatening illness that is not currently under control
- People whom the trial doctor believes would not be able to complete the full study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ming-Yuan Chen, MD,Ph.D, Sun Yat-sen University
Phone: 86-13903052650
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.